222 related articles for article (PubMed ID: 29303289)
21. Therapies in the pipeline for small-cell lung cancer.
Romanidou O; Imbimbo M; Mountzios G; Abidin A; Morgillo F; Califano R
Br Med Bull; 2016 Sep; 119(1):37-48. PubMed ID: 27325208
[TBL] [Abstract][Full Text] [Related]
22. The Role of Immunotherapy in Extensive Stage Small-Cell Lung Cancer: A Review of the Literature.
Tsiouprou I; Zaharias A; Spyratos D
Can Respir J; 2019; 2019():6860432. PubMed ID: 31781314
[TBL] [Abstract][Full Text] [Related]
23. Combination of bevacizumab and dual immunotherapy for extensive-disease small-cell lung cancer: a case report.
Song L; Zhou R; Li X; Pan D
Immunotherapy; 2021 Nov; 13(16):1309-1315. PubMed ID: 34498490
[TBL] [Abstract][Full Text] [Related]
24. A phase II study of topotecan and cisplatin with sequential thoracic radiotherapy in elderly patients with small-cell lung cancer: Okayama Lung Cancer Study Group 0102.
Kubo T; Fujiwara K; Hotta K; Okada T; Kuyama S; Harita S; Ninomiya T; Kamei H; Hosokawa S; Bessho A; Maeda T; Kozuki T; Fujimoto N; Ninomiya K; Takemoto M; Kanazawa S; Takigawa N; Tabata M; Tanimoto M; Ueoka H; Kiura K
Cancer Chemother Pharmacol; 2016 Oct; 78(4):769-74. PubMed ID: 27544764
[TBL] [Abstract][Full Text] [Related]
25. Small cell lung cancer: past, present, and future.
Rodriguez E; Lilenbaum RC
Curr Oncol Rep; 2010 Sep; 12(5):327-34. PubMed ID: 20632219
[TBL] [Abstract][Full Text] [Related]
26. Treatment advances in small cell lung cancer (SCLC).
Waqar SN; Morgensztern D
Pharmacol Ther; 2017 Dec; 180():16-23. PubMed ID: 28579387
[TBL] [Abstract][Full Text] [Related]
27. Small Cell Lung Cancer.
Kalemkerian GP
Semin Respir Crit Care Med; 2016 Oct; 37(5):783-796. PubMed ID: 27732999
[TBL] [Abstract][Full Text] [Related]
28. Mediastinal radiotherapy after multidrug chemotherapy and prophylactic cranial irradiation in patients with SCLC--treatment results after long-term follow-up and literature overview.
Herrmann MK; Bloch E; Overbeck T; Koerber W; Wolff HA; Hille A; Vorwerk H; Hess CF; Muller M; Christiansen H; Pradier O
Cancer Radiother; 2011 Apr; 15(2):81-8. PubMed ID: 20708424
[TBL] [Abstract][Full Text] [Related]
29. Positive Interaction between Prophylactic Cranial Irradiation and Maintenance Sunitinib for Untreated Extensive-Stage Small Cell Lung Cancer Patients After Standard Chemotherapy: A Secondary Analysis of CALGB 30504 (ALLIANCE).
Salama JK; Gu L; Wang X; Pang HH; Bogart JA; Crawford J; Schild SE; Vokes EE; Ready NE
J Thorac Oncol; 2016 Mar; 11(3):361-9. PubMed ID: 26723241
[TBL] [Abstract][Full Text] [Related]
30. Outcome and treatment in elderly patients with small cell lung cancer: a retrospective study.
Li J; Chen P; Dai CH; Li XQ; Bao QL
Geriatr Gerontol Int; 2009 Jun; 9(2):172-82. PubMed ID: 19740361
[TBL] [Abstract][Full Text] [Related]
31. [Current perspectives in the management of small cell lung cancer].
Fujita J; Saijo N
Gan No Rinsho; 1985 Jan; 31(1):1-19. PubMed ID: 2984443
[TBL] [Abstract][Full Text] [Related]
32. Small Cell Lung Cancer: Advances in Diagnosis and Management.
Chauhan AF; Liu SV
Semin Respir Crit Care Med; 2020 Jun; 41(3):435-446. PubMed ID: 32450596
[TBL] [Abstract][Full Text] [Related]
33. Treatment of small cell lung cancer with TRA-8 in combination with cisplatin and radiation.
Bonner JA; Willey CD; Yang ES; Dobelbower MC; Sanford LL; Bright SJ; Buchsbaum DJ; Raisch KP
Radiother Oncol; 2011 Oct; 101(1):183-9. PubMed ID: 21722984
[TBL] [Abstract][Full Text] [Related]
34. Progress and challenges in the treatment of small cell lung cancer.
Tartarone A; Giordano P; Lerose R; Rodriquenz MG; Conca R; Aieta M
Med Oncol; 2017 Jun; 34(6):110. PubMed ID: 28456992
[TBL] [Abstract][Full Text] [Related]
35. [Therapeutic management of poorly differentiated neuroendocrine lung tumors and neuroendocrine carcinomas of the digestive system].
Pellat A; Wislez M; Svrcek M; Hammel P; Afchain P; André T
Bull Cancer; 2016 Oct; 103(10):880-895. PubMed ID: 27507031
[TBL] [Abstract][Full Text] [Related]
36. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
Ariyoshi Y; Fukuoka M; Furuse K; Saijo N; Ikegami H; Nishiwaki Y; Tamura T; Shimoyama M; Suemasu K
Jpn J Clin Oncol; 1994 Oct; 24(5):275-81. PubMed ID: 7967106
[TBL] [Abstract][Full Text] [Related]
37. Clinical outcome of small cell lung cancer with pericardial effusion but without distant metastasis.
Niho S; Kubota K; Yoh K; Goto K; Ohmatsu H; Nihei K; Ohe Y; Nishiwaki Y
J Thorac Oncol; 2011 Apr; 6(4):796-800. PubMed ID: 21258253
[TBL] [Abstract][Full Text] [Related]
38. A new hope: the immunotherapy in small cell lung cancer.
Li Q; Yuan D; Ma C; Liu Y; Ma L; Lv T; Song Y
Neoplasma; 2016; 63(3):342-50. PubMed ID: 26925794
[TBL] [Abstract][Full Text] [Related]
39. Prospects of targeted and immune therapies in SCLC.
Hendriks LEL; Menis J; Reck M
Expert Rev Anticancer Ther; 2019 Feb; 19(2):151-167. PubMed ID: 30590971
[No Abstract] [Full Text] [Related]
40. Rationale for chemotherapy, immunotherapy, and checkpoint blockade in SCLC: beyond traditional treatment approaches.
Spigel DR; Socinski MA
J Thorac Oncol; 2013 May; 8(5):587-98. PubMed ID: 23546044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
